✦ LIBER ✦

Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane+platinum-based regimens

✍ Scribed by C Kosmas; N Tsavaris; C Panopoulos; M Vadiaka; N Stavroyianni; Th Kourelis; N Malamos; M Antonopoulos; H.P Kalofonos

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-483 Gemcitabine and vinorelbine as sec

✍ García Campelo, R.; Alonso Curbera, G.; Gallegos, I.; Quindós, M.; Dopico, D.; R 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Single agent gemcitabine in the second-l

✍ Ugur Coskun; Ali Osman Kaya; Süleyman Buyukberber; Mustafa Benekli; Aytug Uner; 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 147 KB

A phase I–II study of bi-weekly gemcitab

✍ Christos Kosmas; Nicolas Tsavaris; Konstantinos Syrigos; Angelos Koutras; George 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 324 KB

Second-line treatment with gemcitabine a

✍ Herrero, Carlos Camps; Noguerón Martı́nez, Esther; Jaime, Alfonso Berrocal 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Phase II study of weekly chemotherapy wi

✍ Kiyoshi Mori; Yukari Kamiyama; Tetsuro Kondo; Yasuhiko Kano; Tetsuro Kodama 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 330 KB

163 Second line treatment of advanced no

✍ Papadakis, E.; Kourousis, C.; Kakolyris, S.; Androulakis, N.; Dimopoulos, A.M.; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 165 KB